Research / MDLZ / Fundamental state Inspectable configuration
State dimensions Filing 0001103982-19-000005 General Corporate
Debt relative to revenue 22th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
58.79% · OPTIONAL · VALID
Capex intensity 28th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.22% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.22% · OPTIONAL · VALID
Revenue growth 79th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
0.16% · CORE · VALID
Inventory pressure 17th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.99% · OPTIONAL · VALID
Gross margin 78th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
39.91% · CORE · VALID
Operating margin 67th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
12.77% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.40% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 67th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.49% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 8/8 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/9 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 8/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 8/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 236.20%
Current 58.79%
Delta -177.40% Capex Intensity Decreased
Previous 4.42%
Current 4.22%
Delta -0.20% Cash Generation Increased
Previous 11.18%
Current 15.22%
Delta 4.04% Growth Increased
Previous -3.71%
Current 0.16%
Delta 3.87% Inventory Pressure Decreased
Previous 45.20%
Current 9.99%
Delta -35.20% Margin Increased
Previous 38.39%
Current 39.91%
Delta 1.52% Profitability Increased
Previous 11.72%
Current 12.77%
Delta 1.05% Sbc Intensity Increased
Previous 0.40%
Current 0.49%
Delta 0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.